Caseware UK (AP4) 2024.0.164 2024.0.164 21trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-09-01falsedental practice activities10falsefalse 09846845 2024-09-01 2025-08-31 09846845 2025-08-31 09846845 2023-09-01 2024-08-31 09846845 2024-08-31 09846845 c:Director1 2024-09-01 2025-08-31 09846845 c:Director2 2024-09-01 2025-08-31 09846845 d:Buildings 2024-09-01 2025-08-31 09846845 d:Buildings 2025-08-31 09846845 d:Buildings 2024-08-31 09846845 d:Buildings d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09846845 d:PlantMachinery 2024-09-01 2025-08-31 09846845 d:PlantMachinery 2025-08-31 09846845 d:PlantMachinery 2024-08-31 09846845 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09846845 d:OwnedOrFreeholdAssets 2024-09-01 2025-08-31 09846845 d:CurrentFinancialInstruments 2025-08-31 09846845 d:CurrentFinancialInstruments 2024-08-31 09846845 d:Non-currentFinancialInstruments 2025-08-31 09846845 d:Non-currentFinancialInstruments 2024-08-31 09846845 d:CurrentFinancialInstruments d:WithinOneYear 2025-08-31 09846845 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 09846845 d:Non-currentFinancialInstruments d:AfterOneYear 2025-08-31 09846845 d:Non-currentFinancialInstruments d:AfterOneYear 2024-08-31 09846845 d:ShareCapital 2025-08-31 09846845 d:ShareCapital 2024-08-31 09846845 d:RetainedEarningsAccumulatedLosses 2025-08-31 09846845 d:RetainedEarningsAccumulatedLosses 2024-08-31 09846845 c:FRS102 2024-09-01 2025-08-31 09846845 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 09846845 c:FullAccounts 2024-09-01 2025-08-31 09846845 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 09846845 2 2024-09-01 2025-08-31 09846845 6 2024-09-01 2025-08-31 09846845 e:PoundSterling 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure
Registered number: 09846845













A J Sullivan Healthcare Limited

Financial statements
Information for filing with the registrar

31 August 2025




 
A J Sullivan Healthcare Limited


Balance sheet
At 31 August 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
829,596
777,860

Investments
 5 
789,452
789,452

  
1,619,048
1,567,312

Current assets
  

Stock
  
32,179
15,899

Debtors
 6 
163,596
121,808

Cash at bank and in hand
  
206,135
140,024

  
401,910
277,731

Creditors: amounts falling due within one year
 7 
(254,515)
(298,782)

Net current assets/(liabilities)
  
 
 
147,395
 
 
(21,051)

Total assets less current liabilities
  
1,766,443
1,546,261

Creditors: amounts falling due after more than one year
 8 
(546,006)
(593,211)

Provisions for liabilities
  

Deferred tax
  
(51,027)
(34,456)

Net assets
  
1,169,410
918,594


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
1,169,310
918,494

Shareholders' funds
  
1,169,410
918,594


1

 
A J Sullivan Healthcare Limited

    
Balance sheet (continued)
At 31 August 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The company's financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 August 2026.




A J Sullivan
B Sullivan
Director
Director

Company registered number: 09846845
The notes on pages 3 to 7 form part of these financial statements. 

2

 
A J Sullivan Healthcare Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

1.


General information

A J Sullivan Healthcare Limited ("the company") is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is 46-48 Station Road, Llanishen, Cardiff, Wales, CF14 5LU.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared in accordance with Section 1A of Financial Reporting
Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and the Republic
of Ireland' (FRS 102) and the Companies Act 2006.

 
2.2

Revenue

The turnover recognised in the profit and loss account represents NHS, private and capitation scheme income receivable during the period.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

3

 
A J Sullivan Healthcare Limited
 

 
Notes to the financial statements
Year ended 31 August 2025

2.Accounting policies (continued)

 
2.6

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on the following basis:

Depreciation is provided on the following basis:

Freehold property
-
2%
straight line
Plant and machinery
-
25%
reducing balance

 
2.8

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

Investments in unlisted company shares, whose market value can be reliably determined, are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in the statement of comprehensive income for the period. Where market value cannot be reliably determined, such investments are stated at historic cost less impairment.

Investments in listed company shares are remeasured to market value at each balance sheet date. Gains and losses on remeasurement are recognised in profit or loss for the period.

4

 
A J Sullivan Healthcare Limited
 

 
Notes to the financial statements
Year ended 31 August 2025

2.Accounting policies (continued)

 
2.9

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.10

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.11

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 21 (2024 - 10).

5

 
A J Sullivan Healthcare Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

4.


Tangible fixed assets





Freehold property
Plant and machinery
Total

£
£
£



Cost


At 1 September 2024
671,857
397,847
1,069,704


Additions
-
110,230
110,230



At 31 August 2025

671,857
508,077
1,179,934



Depreciation


At 1 September 2024
33,272
258,572
291,844


Charge for the year
13,437
45,057
58,494



At 31 August 2025

46,709
303,629
350,338



Net book value



At 31 August 2025
625,148
204,448
829,596



At 31 August 2024
638,585
139,275
777,860


5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 September 2024
789,452



At 31 August 2025
789,452




6

 
A J Sullivan Healthcare Limited
 
 

Notes to the financial statements
Year ended 31 August 2025

6.


Debtors

2025
2024
£
£


Trade debtors
57,003
73,973

Amounts owed by group undertakings
47,838
47,835

Other debtors
58,755
-

163,596
121,808



7.


Creditors: amounts falling due within one year

2025
2024
£
£

Bank loans
51,911
-

Trade creditors
39,722
227,938

Corporation tax
83,180
54,008

Other taxation and social security
8,780
16,832

Obligations under finance lease and hire purchase contracts
38,246
-

Other creditors
22,252
4

Accruals and deferred income
10,424
-

254,515
298,782



8.


Creditors: amounts falling due after more than one year

2025
2024
£
£

Bank loans
488,252
593,211

Net obligations under finance leases and hire purchase contracts
57,754
-

546,006
593,211



9.


Related party transactions

During the year the company operated an intercompany account with NDP Services Limited to record
amounts due and from the company. At 31 August 2025, the company was owed £47,838 from NDP Services Limited (2024:£47,838).

 
7